Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 15 de 15
1.
Commun Biol ; 6(1): 651, 2023 06 19.
Article En | MEDLINE | ID: mdl-37336943

The voltage-gated K+ channel plays a key role in atrial excitability, conducting the ultra-rapid rectifier K+ current (IKur) and contributing to the repolarization of the atrial action potential. In this study, we examine its regulation by hydrogen sulfide (H2S) in HL-1 cardiomyocytes and in HEK293 cells expressing human Kv1.5. Pacing induced remodeling resulted in shorting action potential duration, enhanced both Kv1.5 channel and H2S producing enzymes protein expression in HL-1 cardiomyocytes. H2S supplementation reduced these remodeling changes and restored action potential duration through inhibition of Kv1.5 channel. H2S also inhibited recombinant hKv1.5, lead to nitric oxide (NO) mediated S-nitrosylation and activated endothelial nitric oxide synthase (eNOS) by increased phosphorylation of Ser1177, prevention of NO formation precluded these effects. Regulation of Ikur by H2S has important cardiovascular implications and represents a novel and potential therapeutic target.


Atrial Fibrillation , Hydrogen Sulfide , Potassium Channels, Voltage-Gated , Humans , Hydrogen Sulfide/pharmacology , Hydrogen Sulfide/metabolism , Atrial Fibrillation/metabolism , HEK293 Cells , Kv1.5 Potassium Channel/genetics , Kv1.5 Potassium Channel/metabolism , Myocytes, Cardiac/metabolism
2.
Sci Rep ; 11(1): 8194, 2021 04 14.
Article En | MEDLINE | ID: mdl-33854181

Hydrogen sulfide (H2S) is gaining interest as a mammalian signalling molecule with wide ranging effects. S-sulfhydration is one mechanism that is emerging as a key post translational modification through which H2S acts. Ion channels and neuronal receptors are key target proteins for S-sulfhydration and this can influence a range of neuronal functions. Voltage-gated K+ channels, including Kv2.1, are fundamental components of neuronal excitability. Here, we show that both recombinant and native rat Kv2.1 channels are inhibited by the H2S donors, NaHS and GYY4137. Biochemical investigations revealed that NaHS treatment leads to S-sulfhydration of the full length wild type Kv2.1 protein which was absent (as was functional regulation by H2S) in the C73A mutant form of the channel. Functional experiments utilising primary rat hippocampal neurons indicated that NaHS augments action potential firing and thereby increases neuronal excitability. These studies highlight an important role for H2S in shaping cellular excitability through S-sulfhydration of Kv2.1 at C73 within the central nervous system.


Hippocampus/cytology , Hydrogen Sulfide/pharmacology , Shab Potassium Channels/genetics , Shab Potassium Channels/metabolism , Action Potentials , Animals , Cells, Cultured , Down-Regulation , HEK293 Cells , Hippocampus/drug effects , Hippocampus/metabolism , Humans , Morpholines/pharmacology , Neurons/cytology , Neurons/drug effects , Neurons/metabolism , Organothiophosphorus Compounds/pharmacology , Phosphorylation , Primary Cell Culture , Rats
3.
Cell Death Dis ; 12(4): 372, 2021 04 07.
Article En | MEDLINE | ID: mdl-33828089

Cellular energy metabolism is fundamental for all biological functions. Cellular proliferation requires extensive metabolic reprogramming and has a high energy demand. The Kv1.3 voltage-gated potassium channel drives cellular proliferation. Kv1.3 channels localise to mitochondria. Using high-resolution respirometry, we show Kv1.3 channels increase oxidative phosphorylation, independently of redox balance, mitochondrial membrane potential or calcium signalling. Kv1.3-induced respiration increased reactive oxygen species production. Reducing reactive oxygen concentrations inhibited Kv1.3-induced proliferation. Selective Kv1.3 mutation identified that channel-induced respiration required an intact voltage sensor and C-terminal ERK1/2 phosphorylation site, but is channel pore independent. We show Kv1.3 channels regulate respiration through a non-conducting mechanism to generate reactive oxygen species which drive proliferation. This study identifies a Kv1.3-mediated mechanism underlying the metabolic regulation of proliferation, which may provide a therapeutic target for diseases characterised by dysfunctional proliferation and cell growth.


Kv1.3 Potassium Channel/metabolism , Reactive Oxygen Species/metabolism , Cell Proliferation/physiology , Cell Respiration/physiology , Humans , Membrane Potentials , Transfection
4.
Cell Death Dis ; 8(11): e3163, 2017 11 02.
Article En | MEDLINE | ID: mdl-29095440

The voltage-gated K+ channel has key roles in the vasculature and in atrial excitability and contributes to apoptosis in various tissues. In this study, we have explored its regulation by carbon monoxide (CO), a product of the cytoprotective heme oxygenase enzymes, and a recognized toxin. CO inhibited recombinant Kv1.5 expressed in HEK293 cells in a concentration-dependent manner that involved multiple signalling pathways. CO inhibition was partially reversed by superoxide dismutase mimetics and by suppression of mitochondrial reactive oxygen species. CO also elevated intracellular nitric oxide (NO) levels. Prevention of NO formation also partially reversed CO inhibition of Kv1.5, as did inhibition of soluble guanylyl cyclase. CO also elevated intracellular peroxynitrite levels, and a peroxynitrite scavenger markedly attenuated the ability of CO to inhibit Kv1.5. CO caused nitrosylation of Kv1.5, an effect that was also observed in C331A and C346A mutant forms of the channel, which had previously been suggested as nitrosylation sites within Kv1.5. Augmentation of Kv1.5 via exposure to hydrogen peroxide was fully reversed by CO. Native Kv1.5 recorded in HL-1 murine atrial cells was also inhibited by CO. Action potentials recorded in HL-1 cells were increased in amplitude and duration by CO, an effect mimicked and occluded by pharmacological inhibition of Kv1.5. Our data indicate that Kv1.5 is a target for modulation by CO via multiple mechanisms. This regulation has important implications for diverse cellular functions, including excitability, contractility and apoptosis.


Carbon Monoxide/pharmacology , Kv1.5 Potassium Channel/metabolism , Animals , Carbon Monoxide/chemistry , Carbon Monoxide/metabolism , Cell Line , HEK293 Cells , Humans , Hydrogen Peroxide/toxicity , Kv1.5 Potassium Channel/antagonists & inhibitors , Kv1.5 Potassium Channel/genetics , Metalloporphyrins/pharmacology , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Mutagenesis, Site-Directed , Nitric Oxide/metabolism , Peroxynitrous Acid/metabolism , Reactive Oxygen Species/metabolism , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification
5.
FASEB J ; 31(11): 4845-4854, 2017 11.
Article En | MEDLINE | ID: mdl-28743763

Exposure to CO causes early afterdepolarization arrhythmias. Previous studies in rats have indicated that arrhythmias arose as a result of augmentation of the late Na+ current. The purpose of the present study was to examine the basis for CO-induced arrhythmias in guinea pig myocytes in which action potentials (APs) more closely resemble those of human myocytes. Whole-cell current- and voltage-clamp recordings were made from isolated guinea pig myocytes as well as from human embryonic kidney 293 (HEK293) cells that express wild-type or a C723S mutant form of ether-a-go-go-related gene (ERG; Kv11.1). We also monitored the formation of peroxynitrite (ONOO-) in HEK293 cells fluorimetrically. CO-applied as the CO-releasing molecule, CORM-2-prolonged the APs and induced early afterdepolarizations in guinea pig myocytes. In HEK293 cells, CO inhibited wild-type, but not C723S mutant, Kv11.1 K+ currents. Inhibition was prevented by an antioxidant, mitochondrial inhibitors, or inhibition of NO formation. CO also raised ONOO- levels, an effect that was reversed by the ONOO- scavenger, FeTPPS [5,10,15,20-tetrakis-(4-sulfonatophenyl)-porphyrinato-iron(III)], which also prevented the CO inhibition of Kv11.1 currents and abolished the effects of CO on Kv11.1 tail currents and APs in guinea pig myocytes. Our data suggest that CO induces arrhythmias in guinea pig cardiac myocytes via the ONOO--mediated inhibition of Kv11.1 K+ channels.-Al-Owais, M. M., Hettiarachchi, N. T., Kirton, H. M., Hardy, M. E., Boyle, J. P., Scragg, J. L., Steele, D. S., Peers, C. A key role for peroxynitrite-mediated inhibition of cardiac ERG (Kv11.1) K+ channels in carbon monoxide-induced proarrhythmic early afterdepolarizations.


Arrhythmias, Cardiac/metabolism , Carbon Monoxide/toxicity , ERG1 Potassium Channel/metabolism , Membrane Potentials/drug effects , Myocytes, Cardiac/metabolism , Peroxynitrous Acid/metabolism , Animals , Arrhythmias, Cardiac/chemically induced , Arrhythmias, Cardiac/genetics , Arrhythmias, Cardiac/pathology , ERG1 Potassium Channel/genetics , Guinea Pigs , HEK293 Cells , Humans , Metalloporphyrins/pharmacology , Myocytes, Cardiac/pathology , Nitric Oxide/genetics , Nitric Oxide/metabolism , Organometallic Compounds/pharmacology , Peroxynitrous Acid/genetics
6.
Cell Death Dis ; 8(6): e2884, 2017 06 15.
Article En | MEDLINE | ID: mdl-28617444

Neurodegeneration in Alzheimer's disease (AD) is extensively studied, and the involvement of astrocytes and other cell types in this process has been described. However, the responses of astrocytes themselves to amyloid ß peptides ((Aß; the widely accepted major toxic factor in AD) is less well understood. Here, we show that Aß(1-42) is toxic to primary cultures of astrocytes. Toxicity does not involve disruption of astrocyte Ca2+ homeostasis, but instead occurs via formation of the toxic reactive species, peroxynitrite. Thus, Aß(1-42) raises peroxynitrite levels in astrocytes, and Aß(1-42) toxicity can be inhibited by antioxidants, or by inhibition of nitric oxide (NO) formation (reactive oxygen species (ROS) and NO combine to form peroxynitrite), or by a scavenger of peroxynitrite. Increased ROS levels observed following Aß(1-42) application were derived from NADPH oxidase. Induction of haem oxygenase-1 (HO-1) protected astrocytes from Aß(1-42) toxicity, and this protective effect was mimicked by application of the carbon monoxide (CO) releasing molecule CORM-2, suggesting HO-1 protection was attributable to its formation of CO. CO suppressed the rise of NADPH oxidase-derived ROS caused by Aß(1-42). Under hypoxic conditions (0.5% O2, 48 h) HO-1 was induced in astrocytes and Aß(1-42) toxicity was significantly reduced, an effect which was reversed by the specific HO-1 inhibitor, QC-15. Our data suggest that Aß(1-42) is toxic to astrocytes, but that induction of HO-1 affords protection against this toxicity due to formation of CO. HO-1 induction, or CO donors, would appear to present attractive possible approaches to provide protection of both neuronal and non-neuronal cell types from the degenerative effects of AD in the central nervous system.


Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Carbon Monoxide/chemistry , Heme Oxygenase (Decyclizing)/metabolism , Peptide Fragments/metabolism , Animals , Animals, Newborn , Antioxidants/chemistry , Astrocytes/cytology , Astrocytes/metabolism , Homeostasis , Neurons/metabolism , Nitric Oxide/chemistry , Peroxynitrous Acid/chemistry , Rats , Rats, Wistar , Reactive Oxygen Species/chemistry , Tetrazolium Salts/chemistry , Thiazoles/chemistry
9.
J Biol Chem ; 290(43): 25907-19, 2015 10 23.
Article En | MEDLINE | ID: mdl-26370078

We have reported previously that a missense mutation in the mitochondrial fission gene Dynamin-related protein 1 (Drp1) underlies the Python mouse model of monogenic dilated cardiomyopathy. The aim of this study was to investigate the consequences of the C452F mutation on Drp1 protein function and to define the cellular sequelae leading to heart failure in the Python monogenic dilated cardiomyopathy model. We found that the C452F mutation increased Drp1 GTPase activity. The mutation also conferred resistance to oligomer disassembly by guanine nucleotides and high ionic strength solutions. In a mouse embryonic fibroblast model, Drp1 C452F cells exhibited abnormal mitochondrial morphology and defective mitophagy. Mitochondria in C452F mouse embryonic fibroblasts were depolarized and had reduced calcium uptake with impaired ATP production by oxidative phosphorylation. In the Python heart, we found a corresponding progressive decline in oxidative phosphorylation with age and activation of sterile inflammation. As a corollary, enhancing autophagy by exposure to a prolonged low-protein diet improved cardiac function in Python mice. In conclusion, failure of Drp1 disassembly impairs mitophagy, leading to a downstream cascade of mitochondrial depolarization, aberrant calcium handling, impaired ATP synthesis, and activation of sterile myocardial inflammation, resulting in heart failure.


Biopolymers/physiology , Dynamins/physiology , Heart Failure/etiology , Mitophagy , Myocarditis/etiology , Animals , Biopolymers/genetics , Biopolymers/metabolism , Cells, Cultured , Dynamins/genetics , Dynamins/metabolism , Heart Failure/physiopathology , Mice , Mutation , Myocarditis/physiopathology , Oxidative Phosphorylation
10.
Metallomics ; 7(5): 867-76, 2015 May.
Article En | MEDLINE | ID: mdl-25781076

Brain iron accumulation has been associated with inciting the generation of oxidative stress in a host of chronic neurological diseases, including Parkinson's disease. Using the catecholaminergic neurotoxin 6-hydroxydopamine to lesion cellular dopaminergic pathways as a model of Parkinson's disease in culture, a selection of 1-hydroxypyridin-2-one (1,2-HOPO) metal chelators were synthesized and their neuroprotective properties were compared to the 3-hydroxypyridin-4-one; deferiprone (3,4-HOPO; DFP). Protection against 6-OHDA and iron insult by the novel compounds 6 and 9 was comparable to DFP. Iron associated changes by 6-OHDA imply that the neuroprotective capacity of these compounds are due to chelation of the neuronal labile iron pool and the requirement of the iron binding moiety of compound 6 for efficacy supported this hypothesis. In conclusion, two novel 1,2-HOPO's and DFP have comparable neuroprotection against Parkinsonian-associated neurotoxins and supports the continued development of hydroxypyridinone compounds as a non-toxic therapeutic agent in the treatment of neurodegenerative disease.


Iron Chelating Agents/chemistry , Iron Chelating Agents/pharmacology , Neuroprotective Agents/chemistry , Neuroprotective Agents/pharmacology , Parkinson Disease, Secondary/prevention & control , Pyridones/chemistry , Pyridones/pharmacology , Cell Line , Crystallography, X-Ray , Deferiprone , Humans , Models, Molecular , Neurons/drug effects , Neurons/pathology , Oxidopamine
11.
Brain Res ; 1443: 75-88, 2012 Mar 14.
Article En | MEDLINE | ID: mdl-22297172

Mutations in the presenilin 1 (PS1) gene lead to early-onset Alzheimer's disease with the S170F mutation causing the earliest reported age of onset. Expression of this, and other PS1 mutations, in SH-SY5Y cells resulted in significant loss of cellular viability compared to control cells. Basal Ca2+ concentrations in PS1 mutants were never lower than controls and prolonged incubation in Ca2+ -free solutions did not deplete Ca2+ stores, demonstrating there was no difference in Ca2+ leak from endoplasmic reticulum (ER) stores in PS1 mutants. Peak muscarine-evoked rises of [Ca2+]i were variable, but the integrals were not significantly different, suggesting, while kinetics of Ca2+ store release might be affected in PS1 mutants, store size was similar. However, when Ca2+ -ATPase activity was irreversibly inhibited with thapsigargin, the S170F and ΔE9 cells showed larger capacitative calcium entry indicating a direct effect on Ca2+ influx pathways. There was no significant effect of any of the mutations on mitochondrial respiration. Amyloid ß(Aß(1-40)) secretion was reduced, and Aß(1-42) secretion increased in the S170F cells resulting in a very large increase in the Aß42/40 ratio. This, rather than any potential disruption of ER Ca2+ stores, is likely to explain the extreme pathology of this mutant.


Cell Survival , Mutation , Presenilin-1/genetics , Presenilin-1/metabolism , Amyloid beta-Peptides/metabolism , Calcium/metabolism , Cell Line, Tumor , Humans , Mitochondria/metabolism
12.
Antioxid Redox Signal ; 17(5): 744-55, 2012 Sep 01.
Article En | MEDLINE | ID: mdl-22360385

AIM: Sublethal carbon monoxide poisoning causes prolonged neurological damage involving oxidative stress. Given the central role of Ca(2+) homeostasis and its vulnerability to stress, we investigated whether CO disrupts neuronal Ca(2+) homeostasis. RESULTS: Cytosolic Ca(2+) transients evoked by muscarine in SH-SY5Y cells were prolonged by CO (applied via the donor CORM-2), and capacitative Ca(2+) entry (CCE) was dramatically enhanced. Ca(2+) store mobilization by cyclopiazonic acid was similarly augmented, as was the subsequent CCE, and that evoked by thapsigargin. Ca(2+) rises evoked by depolarization were also enhanced by CO, and Ca(2+) levels often did not recover in its presence. CO increased intracellular nitric oxide (NO) and all effects of CO were prevented by inhibiting NO formation. However, NO donors did not mimic the effects of CO. The antioxidant ascorbic acid inhibited effects of CO on Ca(2+) signaling, as did the peroxynitrite scavenger, FeTPPS, and CO increased peroxynitrite formation. Finally, CO caused significant loss of plasma membrane Ca(2+)ATPase (PMCA) protein, detected by Western blot, and this was also observed in brain tissue of rats exposed to CO in vivo. INNOVATION: The cellular basis of CO-induced neurotoxicity is currently unknown. Our findings provide the first data to suggest signaling pathways through which CO causes neurological damage, thereby opening up potential targets for therapeutic intervention. CONCLUSION: CO stimulates formation of NO and reactive oxygen species which, via peroxynitrite formation, inhibit Ca(2+) extrusion via PMCA, leading to disruption of Ca(2+) signaling. We propose this contributes to the neurological damage associated with CO toxicity.


Calcium-Transporting ATPases/metabolism , Calcium/metabolism , Carbon Monoxide/pharmacology , Homeostasis/drug effects , Peroxynitrous Acid/pharmacology , Cell Line , Humans , Hydrolysis
13.
Biochem Biophys Res Commun ; 397(3): 564-8, 2010 Jul 02.
Article En | MEDLINE | ID: mdl-20573603

Neuronal gap junctions are receiving increasing attention as a physiological means of intercellular communication, yet our understanding of them is poorly developed when compared to synaptic communication. Using microfluorimetry, we demonstrate that differentiation of SN56 cells (hybridoma cells derived from murine septal neurones) leads to the spontaneous generation of Ca(2+) waves. These waves were unaffected by tetrodotoxin (1microM), but blocked by removal of extracellular Ca(2+), or addition of non-specific Ca(2+) channel inhibitors (Cd(2+) (0.1mM) or Ni(2+) (1mM)). Combined application of antagonists of NMDA receptors (AP5; 100microM), AMPA/kainate receptors (NBQX; 20microM), nicotinic AChR receptors (hexamethonium; 100microM) or inotropic purinoceptors (brilliant blue; 100nM) was also without effect. However, Ca(2+) waves were fully prevented by carbenoxolone (200microM), halothane (3mM) or niflumic acid (100microM), three structurally diverse inhibitors of gap junctions, and mRNA for connexin 36 was detected by PCR. Whole-cell patch-clamp recordings revealed spontaneous inward currents in voltage-clamped cells which we inhibited by Cd(2+), Ni(2+) or niflumic acid. Our data suggest that differentiated SN56 cells generated spontaneous Ca(2+) waves which are propagated by intercellular gap junctions. We propose that this system can be exploited conveniently for the development of neuronal gap junction modulators.


Acetylcholine/metabolism , Calcium Signaling , Calcium/metabolism , Gap Junctions/metabolism , Neurons/metabolism , Animals , Cell Line , Mice , Receptors, Nicotinic/metabolism
14.
J Neurochem ; 111(5): 1192-201, 2009 Dec.
Article En | MEDLINE | ID: mdl-19860837

Parkinson's disease (PD) is characterized in part by the presence of alpha-synuclein (alpha-syn) rich intracellular inclusions (Lewy bodies). Mutations and multiplication of the alpha-synuclein gene (SNCA) are associated with familial PD. Since Ca2+ dyshomeostasis may play an important role in the pathogenesis of PD, we used fluorimetry in fura-2 loaded SH-SY5Y cells to monitor Ca2+ homeostasis in cells stably transfected with either wild-type alpha-syn, the A53T mutant form, the S129D phosphomimetic mutant or with empty vector (which served as control). Voltage-gated Ca2+ influx evoked by exposure of cells to 50 mM K+ was enhanced in cells expressing all three forms of alpha-syn, an effect which was due specifically to increased Ca2+ entry via L-type Ca2+ channels. Mobilization of Ca2+ by muscarine was not strikingly modified by any of the alpha-syn forms, but they all reduced capacitative Ca2+ entry following store depletion caused either by muscarine or thapsigargin. Emptying of stores with cyclopiazonic acid caused similar rises of [Ca2+](i) in all cells tested (with the exception of the S129D mutant), and mitochondrial Ca2+ content was unaffected by any form of alpha-synuclein. However, only WT alpha-syn transfected cells displayed significantly impaired viability. Our findings suggest that alpha-syn regulates Ca2+ entry pathways and, consequently, that abnormal alpha-syn levels may promote neuronal damage through dysregulation of Ca2+ homeostasis.


Calcium Signaling/physiology , Calcium/metabolism , Neuroblastoma/metabolism , alpha-Synuclein/metabolism , Amino Acids/genetics , Analysis of Variance , Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/metabolism , Calcium Signaling/drug effects , Calcium Signaling/genetics , Cell Line, Tumor , Cell Survival/genetics , Enzyme Inhibitors/pharmacology , Fura-2 , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Humans , Indoles/pharmacology , Mutation/genetics , Neuroblastoma/pathology , Neuroblastoma/physiopathology , Nifedipine/pharmacology , Oligomycins/pharmacology , Potassium Chloride/pharmacology , Serine/metabolism , Transfection/methods , alpha-Synuclein/genetics , omega-Conotoxin GVIA/pharmacology
15.
Neuroreport ; 18(10): 1045-8, 2007 Jul 02.
Article En | MEDLINE | ID: mdl-17558293

Prolonged hypoxia alters various cellular processes, including Ca2+ signalling. As these effects can be prevented by antioxidants, we examined the role of glutathione, the major intracellular redox buffer, in modulation of Ca2+ signalling in the human neuroblastoma SH-SY5Y by hypoxia. Rises of [Ca2+]i evoked by bradykinin, and subsequent capacitative Ca2+ entry, were enhanced by prior hypoxia (1% O2, 24 h) without effect on reduced glutathione levels. Glutathione depletion reversed the effects of chronic hypoxia, but did not affect normoxically cultured cells. Elevation of glutathione levels also prevented the effects of hypoxia, but restored such effects in glutathione-depleted cells. Glutathione is therefore required for hypoxia to modify Ca2+ signalling, but its role is more complex than simple buffering of reactive oxygen species.


Calcium Signaling/physiology , Glutathione/metabolism , Hypoxia/physiopathology , Bradykinin/pharmacology , Buthionine Sulfoximine/pharmacology , Calcium Signaling/drug effects , Carmustine/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Humans , Neuroblastoma/metabolism
...